Who to call at Essential Pharma, and when
Fundz watches for the moments Essential Pharma starts buying, and tells you who to reach.
- An alert the day Essential Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Essential Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Essential Pharma. With Fundz connected, it knows.
Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency.
Contract Type
partnership
SurreyBiotechnologyHealth CarePharmaceuticalDescription
Essential Pharma Limited announces a partnership with Nordmark Pharma GmbH to commercialize Norzyme® (pancreas powder) 25,000 gastro-resistant capsules in the UK. This partnership leverages both companies' expertise in pancreatic enzymes, making the treatment available for patients with pancreatic exocrine insufficiency.
Quick answer
Essential Pharma and Nordmark establish partnership for UK availability of Norzyme® capsules for pancreatic insufficiency. (November 9, 2026). Essential Pharma is based in Surrey, England, United Kingdom.
- What agreement did Essential Pharma announce on November 9, 2026?
- Essential Pharma Limited announces a partnership with Nordmark Pharma GmbH to commercialize Norzyme® (pancreas powder) 25,000 gastro-resistant capsules in the UK. This partnership leverages both companies' expertise in pancreatic enzymes, making the treatment available for patients with pancreatic exocrine insufficiency.
- What does Essential Pharma do?
- Essential Pharma is an international specialty pharmaceutical group dedicated to maintaining access to clinically differentiated, niche, branded medicines across multiple therapeutic areas.
- Where is Essential Pharma based?
- Essential Pharma is based in Surrey, England, United Kingdom.
- Which similar companies announced agreements around the same time?
- Daiichi Sankyo Healthcare Co (November 10, 2026), AbbVie Inc. (November 3, 2026), Teva Pharmaceutical Industries Ltd (November 3, 2026) and Alexion (October 29, 2026) also announced agreements within 45 days of Essential Pharma.
Source: Fundz verified event record.
Other recent agreements in Pharmaceutical and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Daiichi Sankyo and iDEL Therapeutics Forge Global Research Partnership for Cancer Drug Development. (November 10, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- Merck Forms Partnership with NVIDIA, Microsoft, and Dawn Health to Enhance Support for Rare Tumor Patients (October 22, 2026)
- DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026)
Related People
Agreement Insights
What this usually meansEssential Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.